Statement Of Changes In Equity [Abstract]

Xbrane Biopharma - Filing #689990

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	424 888 SEK	—	—	—	1 294 227 SEK	885 827 SEK	6 166 SEK	10 322 SEK	—	—	713 313 SEK	431 741 SEK	—	—	—	5 165 SEK	5 614 SEK	1 134 276 SEK	—	—	524 938 SEK	4 977 SEK	3 945 SEK	773 724 SEK	257 709 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	172 513 SEK	172 513 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	188 376 SEK	188 376 SEK	—	—	—	—	—
Other comprehensive income	—	—	5 157 SEK	—	—	—	—	—	—	5 157 SEK	—	—	—	1 220 SEK	—	—	—	—	1 220 SEK	—	—	—	—	—	—
Comprehensive income	—	– SEK	167 356 SEK	172 513 SEK	—	—	—	—	– SEK	5 157 SEK	—	—	– SEK	1 220 SEK	– SEK	—	—	—	187 156 SEK	188 376 SEK	—	—	—	—	—
Issue of equity	—	551,000 SEK	170 551 SEK	—	—	—	—	—	170 000 SEK	—	—	—	380 237 SEK	—	633,000 SEK	—	—	—	380 870 SEK	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	3 301 SEK	—	—	—	—	—	3 301 SEK	—	—	—	4 547 SEK	—	4,000 SEK	—	—	—	4 551 SEK	—	—	—	—	—	—